Ben, a good stock that is oversold presently is IGYN (Imagyn Medical). |
It is still considered by some as a developmental company, having just completed their IPO in June. They have narrowed their quarterly losses in Q2 and Q3 and are ahead of their pro-forma by getting early 510K approval for some of their products that they were scheduled to do PMA approvals from the FDA. Latest press release states that they are doing a rollout of some new products this (Q4) quarter with a new direct sales force. The stock moved up 3 points from where it is presently in the last quarter on the 510K news. It fell back when they met analyst expectations Q3, but did not get on the positive side of the earnings ledger because of fielding a direct sales force. I look for them to increase sales this quarter and next over past analyst expectations, to put them in positive territory earlier than expected.
I look for about a 3 point move over the next 6-8 weeks, with a gap up in January if they exceed predictions. Even analysts with Montgomery expect a double or triple in fiscal '97 from these oversold levels.
I have followed this company since it's IPO and expect it to hit it's stride within the next 6-12 months.
~Good Luck to all.